Quantified Brainwave Data Supports Stronger Cognitive Care for Ann Arbor Patients

Ann Arbor's clinical community operates in close proximity to one of the country's leading academic medical centers, where EEG and ERP research has shaped the science behind cognitive neuroscience for decades. That same ERP technology is now available in a form factor designed for independent practices and specialty clinics: a wireless, FDA-cleared medical device that records the brain's electrical response to structured auditory stimuli and delivers quantified brainwave signatures through an automated standardized report. For clinicians managing patients with concussion histories or early-stage dementia, this means moving from inferential assessment—what does the patient say, how did they score on a screen—to direct physiological measurement of attention and working memory function.

The distinction has practical consequences. A patient recovering from a sports concussion on the University of Michigan campus or a senior presenting to a geriatric practice off Plymouth Road with early memory complaints both benefit from testing that quantifies where brain function actually stands, not where it appears to stand based on their best effort on a paper test. The device records across 9 active electrode channels at 250 samples per second, captures ERP waveform components associated with attention and working memory, and integrates session data into an automated report featuring proprietary algorithms—producing a clinical artifact that documents brain function objectively and comparably across time.

This is the shift that matters most for longitudinal care: baseline data established at the first session becomes the reference point against which every subsequent session is measured.

The testing process requires no hospital infrastructure, shielded room, or specialized facility preparation. The wireless, battery-powered headset accommodates a large range of head sizes, and Hydro-Dot Biosensors replace the electrode gel and scalp preparation required by traditional clinical EEG systems. Setup takes 5 to 10 minutes; the complete testing session runs approximately one hour. Clinical technicians trained on the protocol administer sessions, freeing physicians and neuropsychologists from the time commitment of running the test themselves while maintaining data quality through a standardized procedure that doesn't rely on technician interpretation.

• Auditory stimuli delivered through calibrated insert earphones elicit specific cognitive activity by grouping sounds into sequences that require the brain to apply attention and working memory to track patterns and register responses
• ERP waves generated by the brain's response to these stimuli—particularly the P300 component associated with attentional processing—serve as the primary physiological measure the device captures and quantifies
• Active electrode performance with noise below 1 μV RMS and CMRR exceeding 130dB ensures that subtle ERP components aren't obscured by environmental electrical interference common in busy outpatient environments near US-23
• Lithium-ion battery power and Bluetooth data transmission mean the device can be moved between exam rooms or to satellite locations without infrastructure modifications
• Integrated action buttons collect patient responses during the stimulus sequence, adding a behavioral layer to the electrophysiological recording in the same session

Contact us to learn how Ann Arbor practices can implement this FDA-cleared EEG and ERP device within existing appointment workflows for concussion evaluation and dementia monitoring.

The device was designed with longitudinal monitoring as its primary clinical purpose—tracking patient status and disease progression over time for concussion and dementia. With over 30,000 tests administered, its clinical footprint reflects real-world adoption by providers who found that repeated physiological assessment adds information that serial behavioral testing cannot. For Ann Arbor clinicians building structured monitoring programs, the device provides a consistent data format across every session.

• Concussion patients show measurable ERP changes as recovery progresses—amplitude increases and latency normalization that correlate with functional improvement before patients report full symptom resolution
• Patients whose ERP metrics plateau or worsen between sessions have physiological evidence supporting clinical escalation, medication review, or specialist referral rather than continued watchful waiting
• Dementia monitoring sessions generate quantified working memory and attention data that families and referring physicians can understand without EEG expertise, because the automated report translates waveform data into interpretable metrics
• ACOEM's explicit recommendation of ERP testing via this device type for concussion assessments gives Ann Arbor occupational medicine and sports medicine providers a guideline reference for incorporating the protocol into standard return-to-activity evaluation
• Alzheimer's Association recognition for measuring synaptic activity related to cognitive function supports its use within memory care programs as a complementary physiological monitoring tool

Providers interested in offering patients an objective, physiologically grounded view of brain function over time are encouraged to schedule a consultation to discuss implementation at Ann Arbor clinical practices.